FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs

Hepato-Gastroenterology

Volumn 48, Issue 37, 2001, Pages 197-202

  Iwazaki, S ^a   Takeyoshi, I ^a   Ohwada, S ^a   Sunose, Y ^a   Tsutsumi, H ^a   Kawashima, Y ^a   Matsumoto, K ^a   Morishita, Y ^a  

^a NONE   (Japan)

Author keywords

Extended Liver resection; FR128998; Ischemia reperfusion injury; Platelet activating factor

Indexed keywords

1 BENZYL 10 (3 PYRIDYLMETHYL) 7 THIA 10 AZAPIRO[5,6]DODECAN 11 ONE 7,7 DIOXIDE; FR 128998; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; LIVER BLOOD FLOW; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; LIVER RESECTION; NONHUMAN; PRIORITY JOURNAL;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DOGS; HEPATECTOMY; HEPATIC VEINS; L-LACTATE DEHYDROGENASE; LIVER; LIVER CIRCULATION; LIVER FUNCTION TESTS; PLATELET ACTIVATING FACTOR; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; REPERFUSION; REPERFUSION INJURY; SPIRO COMPOUNDS;

EID: 0035105067     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Microvascular changes of the liver preserved in UW solution. Pathological and immunohistochemical examination
2. Involvement of platelet activating factor in microcirculatory disturbances after global hepatic ischemia
3. Effects of thromboxane A2 synthetase inhibitor on postischemic liver injury in rats
4. Perspectives in platelet-activating factor research
5. Mechanisms of platelet-activating factor induced cardiac depression in the isolated perfused rat heart
6. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats
7. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone
8. Modulation of neutrophil oxidative responses to soluble stimuli by platelet-activating factor
9. Platelet activating factor (PAF) and tumor necrosis factor-α (TNF-α) interactions in endotoxemic shock: Studies with BN 50739, a novel PAF antagonist
10. Ischemia aggravating effects of platelet activating factor in acute myocardial ischemia
11. Mechanisms of the cardioprotective actions of WEB-2170, bepafant, a platelet activating factor antagonist, in myocardial ischemia and reperfusion
12. Protective effects of L-659989, a platelet-activating factor receptor antagonist, in myocardial ischemia and reperfusion in rats
13. Pharmacologic modulation of experimental postischemic hepatic function
14. Effects of platelet-activating factor antagonist E5880 on intrahepatic and systemic metabolic responses to transient hepatic inflow occlusion and reperfusion in the rabbit
15. Effects of platelet-activating factor antagonist on preservation/reperfusion injury of the graft in porcine orthotopic liver transplantation
16. Hepatic ischemia/reperfusion injury: Importance of oxidant/tumor necrosis factor interactions
17. Neutrophil and Kupffer cell induced oxidant stress and ischemia-reperfusion injury in rat liver
18. Biologically active products of stimulated liver macrophages (Kupffer cells)
19. Effects of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation
20. Laser-Doppler flowmetry for estimating liver blood flow
21. GMP-140, a receptor that mediates interactions of leukocytes with activated platelet and endothelium
22. Priming by platelet-activating factor of neutrophil-induced impairment of endothelium-dependent relaxation
23. The effect of hepatic ischemia on liver function and the restoration of liver mass after 70 per cent partial hepatectomy in the dog
24. Does hypothermic perfusion have beneficial effects for ischemic liver during extended hepatectomy with hepatic inflow occlusion of canine liver? A comparative study with topical cooling
25. The effects of FR167653 in extended liver resection with ischemia in dogs